细胞因子及其信号通路在放射性肝损伤发病中的作用研究进展

doi:10.3969/j.issn.1672-5069.2016.06.039

Abstract

Abstract: Radiation-induced liver injury（RILI） is one of the main complications in the radiotherapy of patients with primary liver cancer and abdominal tumors，which limits the radiation doses for the tumor regions and may affects the outcomes of patients at some extent. It is reported that multiple cytokines are closely associated with the pathogenesis of RILI，and cytokines are involved in different stages of RILI by triggering a variety of downstream signaling pathways. In this paper，we try to introduce the latest research of cytokines and their signal transduction pathways related to RILI.

Key words: Radiation-induced liver injury, Cytokines, Signal transduction pathway

Zhou Aibin，Zhou Junping.. Cytokines and their signal transduction pathways in pathogenesis of radiation-induced liver injury[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 766-769.

References

[1] Rahbari NN，Mehrabi A，Mollberg NM，et al. Hepatocellar carcinoma:current management and perspectives for the future. Ann Surg，2011，253（3）:453-469.
[2] 王丽春，赵连三.肝纤维化的实验动物模型. 中国实验动物学报，2014，12（6）:246-249.
[3] Bujold A，Dawson LA.Stereotactic radiation therapy and selective internal radiation therapy for hepatocellular carcioma. Cancer Radiother，2011，15（1）:54-63.
[4] Liang SX，Huang XB，Zhu XD，et al. Dosimetric predictor identification for radiation-induced liver disease after hypofractionated conformal radiotherapy for primary liver carcinoma patients with Child-Pugh Grade A cirrhosis.Radiother Oncol，2011，98（2）:265-269.
[5] 高东伟，于勇华. 细胞因子与放射性肝损伤. 实用肝脏病杂志，2006，9（4）:249-251.
[6] Wei C，Lei X，Ainiwaer A，et al. Molecular responses of radiation-induced liver damage in rats.Mol Med Rep，2015，11（4）:2592-2600.
[7] Chen YX，Zeng ZC，Sun J，et al. Mesenchymal stem cell conditioned medium prevents radiation-induced liver injury by inhibiting inflammation and protecting sinusoidal endothelial cells.Radiat Res，2015，56（4）:700-708.
[8] Sun X，He Y，Ma TT，et al.Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation.Mol Cell Biochem，2014，388（1-2）:11-23.
[9] Yu JL，Li JH，Chengz RG，et al. Effect of matrine on transforming growth factorβ1 and hepatocyte growth factor in rat liver fibrosis model. Asian Pac J Trop Med，2014，7（5）:390-393.
[10] Kajdaniuk D，Marek B，Borgiel Marek H，et al. Transforming growth factor beta1（TGF-β1）in physiology and pathology. Endokrynol Pol，2013，64（5）:384-396.
[11] 吴戈，肖蕾，张瑞丽，等. 急性放射性肝损伤大鼠模型的建立与评价. 中国实验动物学报，2015，23（2）:178-181.
[12] Imaeda M，Ishikawa H，Yoshida Y，et al. Long-term pathological and immunohistochemical features in the liver after intraoperative whole-liver irradiation in rats. J Radiat Res，2014，55（4）:665-673.
[13] 王云莲，艾尼瓦尔·艾木都拉，肖蕾，等.血清转化生长因子β1在大鼠放射性肝纤维化中的动态表达及其相关性研究.现代生物医学进展，2014，14（30）:5829-5832.
[14] Bai Q，An J，Wu X，et al. HBV promotes the proliferation of hepatic stellate cells via the PDGF-B/PDGFR-βsignalling pathway in vitro.Int J Mol Med，2012，30（6）:1443-1450.
[15] 李东，李新宇，龚钰清，等. PDGF-BB、TGF-β1与肝纤维化的相关性研究. 海南医学，2012，23（21）：99-100.
[16] Velasco-Loyden G，Pérez-Carreón JI，Agüero JF，et al.Prevention of in vitro hepatic stellate cells activation by the adenosine derivative compound IFC 305.Biochem Pharmacol，2010，80（11）:1690-1699.
[17] Borkham-Kamphorst E，Kovalenko E，Van Roeyen CR，et al.Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury.Lab Inves，2008，88（10）:1090-1100.
[18] Leask A，Holmes A，Black C M，et al. Connective tissue growth factor gene regulation.Requirements for its induction by transforming growth factor-beta 2 in fibroblasts.J Biol Chem，2003，278（15）:13008-130015.
[19] 胡云龙，孔丽. TGF-β1，CTGF信号传导通路在小鼠肝纤维化发生中的作用. 基础医学与临床，2012，32（1）:66-70.
[20] Yu FJ，Dong PH，Fan XF，et al. Down-regulation of angiotensinⅡby shRNA reduces collagen synthesis in hepatic stellate cells.Int J Mol Med，2010，25（5）:801-806.
[21] Ponmari G，Annamalai A，Gopalakrishnan VK，et al. NF-κB activation and proinflammatory cytokines mediated protective effect of indigofera caerulea Roxb on CCl4 induced liver damage in rats.Int Immunopharmacol，2014，23（2）:672-680.
[22] 李亚萍，党双锁，翟嵩，等. NF-κB、α-SMA及TGFβ1在实验性肝损伤中的表达. 临床肝胆病杂志，2011，27（11）：1207-1210.
[23] Kim BH，Yoon JH，Yang JI，et al. Guggulsterone attenuates activation and survival of hepatic stellate cell by inhibiting nuclear factor kappa B activation and inducing apoptosis. J Gastroenterol Hepatol，2013，28（12）：1858-1868.
[24] 高世乐，胡宗涛，秦峰，等. Smads蛋白家族在大鼠放射性肝纤维化形成过程中的表达.实验动物与比较医学，2015，35（3）：188-194.
[25] Jazirehi AR，Wenn PB，Damavand M. Therapeutic implications of targeting the PI3kinase/AKT/mTOR signaling module in melanoma therapy.Am J Cancer Res，2012，2（2）:178-191.
[26] Pal I，Mandal M. PI3K and AKt as molecular targets for cancer therapy:current clinincal outcomes. Acta Pharmacol Sin，2012，33（12）:1441-1458.
[27] 罗晓旭，肖蕾，吴戈，等. PI3K/Akt信号通路与肝星状细胞活化的关系及其在放射性肝纤维化中的作用. 中华放射医学与防护杂志，2015，35（9）：652-655.
[28] 管洪庚，徐永锋，兰晶.血小板源生长因子通过PI3K/AKT途径促肝星状细胞增殖与Ⅰ型胶原合成.中华实验外科杂志，2007，24（11）：1332-1334.
[29] Jatiani SS，Baker SJ，Silverman LR，et al. JAK/STAT pathways in cytokine signaling and myeloproliferative disorder:approaches for targeted therapies. Genes Cancer，2010，1（10）:979-993.
[30] Lakner AM，Moore CC，Gulledge AA，et al. Daily genetic profiling indicates JAK/STAT signaling promotes early hepatic stellate cell transdifferentiation.World J Gastroenterol，2010，16（40）:5047-5056.
[31] Cipolletta E，Monaco S，Maione AS，et al. Calmodulin-dependent kinase Ⅱmediates vascular smooth muscle cell proliferation and is potentiated by extracellular signal regulated kinase.Endocrinology，2010，151（6）:2747-2759.
[32] 陈莲香，舒建昌. PDGF 与肝纤维化关系的研究新进展. 胃肠病学和肝病学杂志，2011，20（1）：95-98.
[33] Kaji K，Yoshiji H，Ikenaka Y，et al. DipeptidyI peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats. J Gastroenterol，2014，49（3）:481-491.
[34] 陈暑波，冯军，赵帆，等. 大鼠急性放射性肝损伤TGF-β1和α-SMA的表达变化. 中国现代医学杂志，2015，25（1）:12-15.
[35] Chun J，Zhang X，Jin L，et al.Protective effects of caffeic acid phenethyl ester against acute radiation-induced hepatic injury in rats.Environ Toxicol Pharmacol，2015，39（2）:683-689.
[36] Du SS，Qiang M，Zeng ZC，et al. Radiation-induced liver fibrosis is mitigated by gene therapy inhibiting transforming growth factor-β signaling in the rat.Int J Radiat Oncol Biol Phys，2010，78（5）：1513-1523.

Cytokines and their signal transduction pathways in pathogenesis of radiation-induced liver injury

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Min Feng, Huang Wenqi, Wu Weibing, et al.. Implications of serum adipocytokine levels in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
[2]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[3]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[4]	Yan Xisheng, Li Wei, Wang Jian, et al. Changes of serum cytokines and intestinal flora distribution in patients with alcoholic liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 518-521.
[5]	Wang Yuan, Dang Panyu, Wang Wei. Application of plasma exchange and continuous plasma dialysis filtration in the treatment of patients with acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 541-544.
[6]	Wang Chan, Qin Wei, Dai Yong, et al.. Clinical efficacy of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 97-100.
[7]	Zhou Sisi, Shen Youxiu, Li Juan, et al.. Changes of peripheral blood Th17 and Treg cells and their related serum cytokines in patients with chronic hepatitis C and liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 689-692.
[8]	Sui Ling, Du Jikun, Zheng Jingbin.. Protective effect of curcumin on CCl₄-induced acute liver injury in rats [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 709-712.
[9]	Zhou Zhiqing, Huang Yongdong. Efficacy of polyene phosphatidylcholine in patients with moderate -to-severe nonalcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 733-736.
[10]	Zhu Zhihua, Cong Zaihong, Liu Aixia, et al.. Effects of sub-dose ketamine combined with total intravenous anesthesia on cognitive function and serum pro-inflammatory cytokine levels in elderly patients undergoing laparoscopic cholecystectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 773-776.
[11]	Qin Wenying, Chen Lihua, Yu Guojun. Application of paravertebral block anesthesia combined with general anesthesia in patients with hepatic hemangioma resection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 605-608.
[12]	Luo Dan, Chen Yong, Chen Qing, et al. Effect of pegylated interferon α-2b on peripheral blood T lymphocyte subsets and serum cytokine levels in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 200-203.
[13]	Li Hongzhe, Wu Jinhai. Efficacy of combination of entecavir and herbal medicine in the treatment of patients with compensated hepatitis B liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(6): 762-763.
[14]	Sun Xiao. Application of microecological agents and enteral nutrition in patients with hepatic encephalopathy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(6): 777-778.
[15]	Xiao Yuzhu.. Combination of adefovir dipivoxil and entecavir in treatment of elderly patients with decompensated hepatitis B-induced liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(5): 546-549.